POET Technologies Inc experienced a significant pre-market surge of 9.29%, continuing its positive momentum in early trading sessions.
The rally is driven by growing investor confidence in the company's commercialization trajectory, highlighted by a $400 million investment secured in May and a $500 million procurement agreement with Lumilens. These developments mark a significant acceleration in the commercial deployment of POET's Optical Interposer platform.
Further supporting the positive sentiment, a recent investment research report issued a target price range of $18-22 for the stock, emphasizing the platform's competitive advantages including its ability to reduce assembly costs by 70% and achieve 90% yield rates compared to the industry average of 70%.
Comments